NDC 60505-2657-01 - Triamterene and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 60505-2657
- Requested NDC
- 60505-2657-01
- Package NDCs from labels
- 60505-2657-1, 60505-2657-5, 60505-2657-7, 60505-2657-01
- Manufacturer
- Apotex Corp. | Apotex Inc.
- Effective date
- 2026-02-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Triamterene and Hydrochlorothiazide Tablets, 37.5 mg/ 25 mg and 75 mg/50 mg | Apotex Corp. | Apotex Inc. | 2026-02-17 | HUMAN PRESCRIPTION DRUG LABEL |
| Triamterene and Hydrochlorothiazide - Northwind Health Company, LLC | Northwind Health Company, LLC | 2026-01-01 | HUMAN PRESCRIPTION DRUG LABEL |
| Triamterene and Hydrochlorothiazide - Bryant Ranch Prepack | Bryant Ranch Prepack | 2025-09-12 | HUMAN PRESCRIPTION DRUG LABEL |
| Triamterene and Hydrochlorothiazide - A-S Medication Solutions | A-S Medication Solutions | 2023-02-04 | HUMAN PRESCRIPTION DRUG LABEL |
| Triamterene and Hydrochlorothiazide - Aphena Pharma Solutions - Tennessee, LLC | Aphena Pharma Solutions - Tennessee, LLC | 2020-11-12 | HUMAN PRESCRIPTION DRUG LABEL |
| Triamterene and Hydrochlorothiazide Tablets, 37.5 mg/ 25 mg and 75 mg/50 mg | Preferred Pharmaceuticals, Inc. | 2020-06-01 | HUMAN PRESCRIPTION DRUG LABEL |
| Triamterene and Hydrochlorothiazide Tablets, 37.5 mg/ 25 mg and 75 mg/50 mg | NuCare Pharmaceuticals,Inc. | 2017-12-26 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60505-2657-1 | Triamterene and Hydrochlorothiazide | 100 in 1 BOTTLE | TABLET | 100 | 10 | |
| 60505-2657-5 | Triamterene and Hydrochlorothiazide | 500 in 1 BOTTLE | TABLET | 500 | 10 | |
| 60505-2657-7 | Triamterene and Hydrochlorothiazide | 7000 in 1 BOTTLE | TABLET | 7000 | 10 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 60505-2657 | TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [APOTEX CORP.] | 7 | Current NDC, Legacy NDC, 3 package rows | 20241004_bd6c3495-ec70-908b-482a-a979506659e9.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60505-2657-1 | EA - Each | 60505-2657 | 27051dbe-be18-4397-b230-74d9142c0dc4 | 1 | 2012-07-24 |
| 60505-2657-5 | EA - Each | 60505-2657 | 2c5f8ced-9db8-4e27-94c8-3536ad44ae66 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 5ee165a3-39a4-4d12-aff2-a6fb3309ce39 | 2026-09-08 | Boxed warning, Warnings, Adverse reactions | 310818 WS821Z52LQ 0J48LPH2TH |
| Telmisartan and Hydrochlorothiazide | TELMISARTAN AND HYDROCHLOROTHIAZIDE | AvKARE | 1b303136-dccd-178b-e063-6394a90a35f8 | 2026-09-08 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 7dc3414b-dcb5-4b11-bca7-c0fa3f474aea | 2026-09-03 | Boxed warning, Adverse reactions | WS821Z52LQ 0J48LPH2TH |
| Olmesartan Medoxomil and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Umedica Laboratories USA Inc. | 55d6aee1-01ca-4791-8404-386664b4ab07 | 2026-09-02 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Edenbridge Pharmaceuticals LLC. | 295532b5-65c8-40c3-8d27-cfd334d12802 | 2026-08-28 | Warnings, Adverse reactions | 0J48LPH2TH |
| olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 57ffeef7-bfa8-4f92-aadc-23cd00022607 | 2026-08-28 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | f20fd735-30c7-4f89-8ceb-b6186646eea6 | 2026-08-27 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 8e0683e2-5473-4246-97ae-b71c21c39ac7 | 2026-08-26 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | 8bc8d5e2-a974-64ed-e053-2a95a90a8340 | 2026-08-25 | Warnings, Adverse reactions | 0J48LPH2TH |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 53221419-204c-40a2-9ec3-8e4b994dd39d | 2026-08-20 | Warnings, Adverse reactions | 0J48LPH2TH |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 12ba7eba-1874-41b6-aff5-7baba8b99984 | 2026-08-20 | Warnings, Adverse reactions | 0J48LPH2TH |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 154cb1d2-9fb2-4c8d-90de-6a8062a8d1ba | 2026-08-19 | Warnings, Adverse reactions | 0J48LPH2TH |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | ANI Pharmaceuticals, Inc. | a26bcf78-6515-4e9f-b2dc-4aaa8ec1a82c | 2026-08-12 | Warnings, Adverse reactions | 0J48LPH2TH |
| bisoprolol fumarate and hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Teva Pharmaceuticals USA, Inc. | 27d52b23-e3e2-4339-b00e-cd0fec43ffbb | 2026-08-11 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | REMEDYREPACK INC. | 3bea11a3-eb07-46b2-9b91-f8a48a2f3b7e | 2026-08-11 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | fd07d24c-6db1-4f6b-b226-68abba3a3321 | 2026-08-07 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 446e6998-01f6-4de0-be57-7fecf5448e95 | 2026-08-07 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| bisoprolol fumarate and hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Unichem Pharmaceuticals (USA), Inc. | b9ee689a-ea12-435d-b01c-70d45891e62f | 2026-08-06 | Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 31a3d1cb-0f52-4818-965d-7584374bb23e | 2026-08-06 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | Proficient Rx LP | 43a4d6dd-bcca-412c-b051-ed470208ddb6 | 2026-08-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.